Showing results (11-20 of 171) with videos related to
Sort By:
Pageof 18
Antimicrobial Agents and Chemotherapy|May 20, 2009
In vitro activities of telavancin and vancomycin against biofilm-producing Staphylococcus aureus, S. epidermidis, and Enterococcus faecalis strainsKerry L LaPlante, Leonard A MermelPM & R : the Journal of Injury, Function, and Rehabilitation|May 29, 2012
Spine osteoarthritisBen L Laplante, Michael J DePalmaAntimicrobial Agents and Chemotherapy|November 25, 2004
Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic modelKerry L LaPlante, Michael J RybakAmerican Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 9, 2007
Telavancin: a novel lipoglycopeptide antimicrobial agentRyan J Attwood, Kerry L LaPlanteDiagnostic Microbiology and Infectious Disease|August 24, 2010
In vitro activity of tigecycline in combination with gentamicin against biofilm-forming Staphylococcus aureusKevin W McConeghy, Kerry L LaPlanteExpert Opinion on Pharmacotherapy|October 27, 2004
Daptomycin - a novel antibiotic against Gram-positive pathogensKerry L LaPlante, Michael J RybakInfection|December 14, 2011
Changing epidemiology of methicillin-resistant Staphylococcus aureus in the Veterans Affairs Healthcare System, 2002-2009A R Caffrey, K L LaPlantePharmacotherapy|March 16, 2005
Community-associated methicillin-resistant Staphylococcus aureus: a reviewMichael J Rybak, Kerry L LaPlanteDiagnostic Microbiology and Infectious Disease|October 12, 2004
Clinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecyclineKerry L LaPlante, Michael J RybakPageof 18